Missing/wrong data?
Log in to edit
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.
scientific article
Author/s
author: Axel Le Cesne, Jean-Yves Blay, Paolo Giovanni Casali, Jaap Verweij, Martine van Glabbeke, Ian Judson, Marcus Schlemmer, John Zalcberg, Peter Reichardt
Work details
Publication date
August 1, 2005
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.